SEC 13F Intelligence

ODONATE THERAPEUTICS INC

CUSIP 676079106

Odonate Therapeutics Inc has 40 institutional holders in Filings Flow’s 13F database, together reporting 22.58M shares worth $32M as of Q4 2021.

Institutional Holders
40
Q4 2021
Reported Value
$32M
Ticker
unmapped
private placement or foreign
Quarters Tracked
6

Ownership Trend

Institutional holders
Q4 ’18: 34Q4 ’18Q1 ’19: 36Q1 ’19Q2 ’19: 52Q2 ’19Q3 ’19: 60Q3 ’19Q2 ’21: 54Q2 ’21Q4 ’21: 40Q4 ’21filingsflow.com
Total reported value
Q4 ’18: $291MQ4 ’18Q1 ’19: $456MQ1 ’19Q2 ’19: $859MQ2 ’19Q3 ’19: $638MQ3 ’19Q2 ’21: $103MQ2 ’21Q4 ’21: $32MQ4 ’21filingsflow.com

Holders

Export to Excel
Manager% of PortfolioValueSharesQuarter
MetLife Investment Management, LLC$19.6B AUM0.00%$251,5425.9KQ1 2024

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.